首页 | 本学科首页   官方微博 | 高级检索  
     

睾丸的原发性NK/T细胞淋巴瘤一例报告及文献复习
引用本文:Qinbing Zeng Fanjun Cheng Qingping Gao Zhengpeng Zhu Qihuan Liu Qiang Yu Jian Lu. 睾丸的原发性NK/T细胞淋巴瘤一例报告及文献复习[J]. 中德临床肿瘤学杂志, 2007, 6(6): 596-600. DOI: 10.1007/s10330-007-0111-7
作者姓名:Qinbing Zeng Fanjun Cheng Qingping Gao Zhengpeng Zhu Qihuan Liu Qiang Yu Jian Lu
作者单位:[1]Department of Hematology, Dongfeng General Hospital, Yunyang Medical College, Shiyan 442008, China [2]Department of Hematology, Renmin Hospital, Medical College of Wuhan University, Wuhan 430060, China
基金项目:Supported by YMC Youth Team of Science & Technology Innovation Funding (No. 2005CXG 02).
摘    要:
Objective: To study the clinical and pathological features of primary NK/T cell lymphoma of testis and to investigate the effective diagnosis and treatment of this disease. Methods: The surgical specimens of a patient with primary NK/T cell lymphoma of the testis were observed by light microscopy, immunohistochemistry and examined by the polymerase chain reaction (PCR) for Epstein-Barr virus (EBV) DNA and T-cell receptor (TCR) gene rearrangement, and the literature were reviewed. Results: The patient presented with left-sided painless testicular enlargement and the lymphoma had a propensity to spread to the contralateral testis, spleen, central nervous system, and so on. The neoplastic cells were positive for CD56, CD45R0 and CD3ε, while the expressions of CD20, CD79α, CD5, Bcl-2 and PLAP were negative. In addition, the EBV DNA was detected in the lymphoma by PCR. And the results of gene rearrangement studies for the y chain of the T-cell receptor were negative. The pathological diagnosis was NK/T cell lymphoma of the left testis. Conclusion: Primary NK/T cell lymphoma of the testis is a rare entity and progressed rapidly. The histopathological, immunohistochemical, EBV examination and TCR gene rearrangement studies should be carried out as soon as possible in order to get the defined diagnosis. Currently, the therapeutic efficacy is poor and the new measures should be investigated to improve the survival rate.

关 键 词:淋巴瘤 睾丸 治疗方法 抗原体
收稿时间:2007-06-05
修稿时间:2007-10-15

Primary NK/T cell lymphoma of the testis: A case report and review of the literature
Qinbing Zeng,Fanjun Cheng,Qingping Gao,Zhengpeng Zhu,Qihuan Liu,Qiang Yu,Jian Lu. Primary NK/T cell lymphoma of the testis: A case report and review of the literature[J]. The Chinese-German Journal of Clinical Oncology, 2007, 6(6): 596-600. DOI: 10.1007/s10330-007-0111-7
Authors:Qinbing Zeng  Fanjun Cheng  Qingping Gao  Zhengpeng Zhu  Qihuan Liu  Qiang Yu  Jian Lu
Affiliation:(1) Department of Hematology, Dongfeng General Hospital, Yunyang Medical College, Shiyan, 442008, China;(2) Department of Hematology, Renmin Hospital, Medical College of Wuhan University, Wuhan, 430060, China
Abstract:
Objective To study the clinical and pathological features of primary NK/T cell lymphoma of testis and to investigate the effective diagnosis and treatment of this disease. Methods The surgical specimens of a patient with primary NK/T cell lymphoma of the testis were observed by light microscopy, immunohistochemistry and examined by the polymerase chain reaction (PCR) for Epstein-Barr virus (EBV) DNA and T-cell receptor (TCR) gene rearrangement, and the literature were reviewed. Results The patient presented with left-sided painless testicular enlargement and the lymphoma had a propensity to spread to the contralateral testis, spleen, central nervous system, and so on. The neoplastic cells were positive for CD56, CD45R0 and CD3ɛ, while the expressions of CD20, CD79α, CD5, Bcl-2 and PLAP were negative. In addition, the EBV DNA was detected in the lymphoma by PCR. And the results of gene rearrangement studies for the γ chain of the T-cell receptor were negative. The pathological diagnosis was NK/T cell lymphoma of the left testis. Conclusion Primary NK/T cell lymphoma of the testis is a rare entity and progressed rapidly. The histopathological, immunohistochemical, EBV examination and TCR gene rearrangement studies should be carried out as soon as possible in order to get the defined diagnosis. Currently, the therapeutic efficacy is poor and the new measures should be investigated to improve the survival rate. Supported by YMC Youth Team of Science & Technology Innovation Funding (No. 2005CXG 02).
Keywords:lymphoma  killer cell,natural,T-cell  testis  antigen  CD56
本文献已被 维普 万方数据 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号